Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Diana Giannarelli and Marco Di Maio.
Diana Giannarelli
Connection Strength
0.209
Marco Di Maio
  1. Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG. Ther Adv Med Oncol. 2020; 12:1758835920968463.
    View in: PubMed
    Score: 0.057
  2. Assessing Financial Toxicity in Patients With Cancer: Moving Away From a One-Size-Fits-All Approach. J Oncol Pract. 2019 08; 15(8):460-461.
    View in: PubMed
    Score: 0.052
  3. State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enough. Crit Rev Oncol Hematol. 2019 Jul; 139:87-90.
    View in: PubMed
    Score: 0.051
  4. [Influenza vaccination in advanced cancer patients undergoing immunotherapy with anti-PD-1/PD-L1 immune checkpoint inhibitors: what data do we have for the clinical recommendation?] Recenti Prog Med. 2018 Nov; 109(11):540-546.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.